ver, acyclic nucleosides have a long history of success and safety in the clinic as antiviral agents against herpes virus, HIV, and HBV • Valtrex, acyclow, & Famvir • Epiphany is developing EPB-510 as the first acyclic nucleotide polymerase family to target HCV • Epiphany controls IP around EPB-510, a new cl